11 Best Rising Penny Stocks to Buy According to Hedge Funds

Page 10 of 10

1. Gossamer Bio, Inc. (NASDAQ:GOSS)

Price: $2.34

1 Month Performance: 31.46%

Number of Hedge Fund Holders: 31

Gossamer Bio, Inc. (NASDAQ:GOSS) is one of the Best Rising Penny Stocks to Buy According to Hedge Funds. On August 5, Gossamer Bio, Inc. (NASDAQ:GOSS) provided second-quarter results and a business update, highlighting the completion of enrollment for its Phase 3 PROSERA Study. The Market has taken the update positively, as the share price has surged more than 8.5% since the announcement.

Recently, on August 19, Patrick Trucchio, analyst from H.C. Wainwright, reiterated a Buy rating on Gossamer Bio, Inc. (NASDAQ:GOSS), with a price target of $10. He noted that the 2025 literature review for Seralutinib has increased confidence in the drug’s lasting effects and also confirmed its relevance to right-heart function. The open-label phase two trial showed sustained improvements among patients, as over seventy-two weeks, there was a drop in pulmonary vascular resistance and better six-minute walk distances.

Management expects results from the Phase 3 PROSERA Study in February 2026; analysts believe this would further prove the drug’s long-term safety and effectiveness.

Gossamer Bio, Inc. (NASDAQ:GOSS) is a clinical-stage biopharmaceutical company developing Seralutinib, a drug for treating pulmonary arterial hypertension and pulmonary hypertension linked to interstitial lung disease.

While we acknowledge the potential of GOSS to grow, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than GOSS and that has 100x upside potential, check out our report about this cheapest AI stock.

READ NEXT: The Best and Worst Dow Stocks for the Next 12 Months and 10 Unstoppable Stocks That Could Double Your Money.

Disclosure: None. Insider Monkey focuses on uncovering the best investment ideas of hedge funds and insiders. Please subscribe to our free daily e-newsletter to get the latest investment ideas from hedge funds’ investor letters by entering your email address below.

Page 10 of 10